Compound information
- Natural Products
- ZC1071941
- Molecular Formula
- C10H8N2OS2
- Molecular Weight
- 236.007804876 g/mol
- Structure
-
- IUPAC Name
- N-[4-(2-thienyl)thiazol-2-yl]prop-2-enamide
- InChI
- InChI=1S/C10H8N2OS2/c1-2-9(13)12-10-11-7(6-15-10)8-4-3-5-14-8/h2-6H,1H2,(H,11,12,13)
- InChI Key
- MLMVHPZCFGSWIV-UHFFFAOYSA-N
- SMILES
- C=CC(=O)Nc1nc(-c2cccs2)cs1
- Source
- ZINC001775997616
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 15 | Ring Count | 2 |
Heteroatom Count | 5 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 41.99 Å2 | LogP | 3.127 |
LogS | -3.95 | LogD | 4.022 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.148 | Pgp substrate | 0.012 |
HIA | 0.96 | F20 % | 0.994 |
F30 % | 0.522 | Caco-2 | -4.586 |
MDCK | -4.58 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.055 | PPB | 94.667 |
VD | 0.504 | Fu | 1.484 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 1.0 | CYP1A2 substrate | 0.675 |
CYP2A6 substrate | 0.568 | CYP2B6 substrate | 0.713 |
CYP2C19 inhibitor | 0.831 | CYP2C19 substrate | 0.735 |
CYP2C8 substrate | 0.554 | CYP2C9 inhibitor | 0.867 |
CYP2C9 substrate | 0.022 | CYP2D6 inhibitor | 0.005 |
CYP2D6 substrate | 0.455 | CYP2E1 substrate | 0.522 |
CYP3A4 inhibitor | 0.128 | CYP3A4 substrate | 0.924 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.343 | CL | 7.633 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.152 | Hepatotoxicity | 0.282 |
Mutagenicity | 0.005 | Rat Oral Acute Toxicity | 0.005 |
FDAMDD | 0.27 | Skin Sensitization | 0.959 |
Carcinogenicity | 0.011 | Eye Corrosion | 0.006 |
Eye Irritation | 0.536 | Respiratory Toxicity | 0.935 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.333 | IGC50 | 3.709 |
LC50FM | 5.745 | LC50DM | 5.513 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.732 | NR-AR-LBD | 0.513 |
NR-AhR | 0.96 | NR-Aromatase | 0.071 |
NR-ER | 0.732 | NR-ER-LBD | 0.604 |
NR-PPAR-gamma | 0.915 | SR-ARE | 0.941 |
SR-ATAD5 | 0.882 | SR-HSE | 0.709 |
SR-MMP | 0.972 | SR-p53 | 0.845 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.